Services-Direct Mail Advertising Services · SIC 7331

HARTE HANKS INC

HHS

Watch

Latest revenue

$37.3M

as of 2026-03-31

Latest net income

$-628.0K

as of 2026-03-31

Net margin

-1.7%

as of 2026-03-31

8.1
of 10

ActaClear Score

Strong
#1 of 2 in Services-Direct Mail Advertising Services
+1.2 · 2d
Profitability·25%
10.0
Growth·15%
0.0
Value·20%
10.0
Quality·20%
Momentum·20%
10.0

Computed from 5 years of SEC fundamentals + latest market data, ranked within Services-Direct Mail Advertising Services (2 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 7, 2026.

Community sentiment

Where do you think HHS is heading?

1 month
6 months
12 months
5 years
Sign in free to vote and see community sentiment

Price · 5Y

-30.5% / yr 50.2 pts / yr vs S&P 500 76.6% total
Compare:

Live market

delayed ≤15 min
$2.56
1.79%
Market cap
$19.0M
Enterprise value
$12.4M
P/E (trailing)
Forward P/E
P/B
0.94×
Dividend yield
0.0%
52-wk high
$5.39
52-wk low
$2.22
Beta
Shares out
7.4M

5-year trend

What this company does

AI

ITEM 1. BUSINESS INTRODUCTION Harte Hanks, Inc., together with its subsidiaries (“Harte Hanks,” “Company,” “we,” “our,” or “us”) is a global Business Experience Outsourcing company. We operate at the intersection of data, marketing , sales, customer care, fulfillment, and logistics integrating front office revenue growth and customer experience operations with back office execution to deliver measurable business outcomes. With offices in North America, Asia-Pacific and Europe, we serve leading global brands enabling them to design, activate and optimize the full customer and product lifecycle. We are the successor to a newspaper business started by Houston Harte and Bernard Hanks in Texas…

AI summary unavailable — showing raw filing excerpt

Generated from HHS's filing dated 2026-03-17

Key risks

AI

ITEM 1A. RISK FACTORS This section discusses the most significant factors that could affect our business, results of operations and financial condition, including the price of our common stock. You should carefully consider the following risks, which represent the material risk factors that affect the Company and are known to the Company at this time, as well as the other information contained in this Annual Report on Form 10-K in evaluating our company and our common stock. The risks described below are not the only ones we face. Additional risks not presently known to us or that we currently deem immaterial may also adversely affect our business, results of operations, or financial…

AI summary unavailable — showing raw filing excerpt

Generated from HHS's filing dated 2026-03-17

Profitability

Operating margin

0.2%

78.6%

Net margin

-0.5%

96.9%

Return on equity

-4.0%

97.4%

Return on assets

-0.9%

97.0%

Leverage

Debt / equity

3.47×

15.8%

Long-term debt / equity

0.00×

100.0%

Debt / assets

77.6%

3.5%

Earnings tracker

QuarterRevenueYoYNet incomeYoYNet margin

Q1 2026

2026-03-31

$37.3M-10.3%$-628.0K-60.2%-1.7%

Q4 2025

2025-12-31

$39.9M-15.4%$2.2M+190.5%5.5%

Q3 2025

2025-09-30

$39.5M-17.0%$-2.3M-1709.9%-5.8%

Q2 2025

2025-06-30

$38.6M-14.2%$-335.0K+98.8%-0.9%

Q1 2025

2025-03-31

$41.6M-8.6%$-392.0K-129.2%-0.9%

Q4 2024

2024-12-31

$47.1M$-2.4M-5.2%

Q3 2024

2024-09-30

$47.6M+1.1%$142.0K-65.1%0.3%

Q2 2024

2024-06-30

$45.0M-5.7%$-27.8M-13091.5%-61.8%

Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.

Industry trend

Services-Direct Mail Advertising Services · SIC 7331

Your notes

Keep private notes on HHS — thesis, target price, catalysts to watch.

Visible only to you. Never shared. Never used to train AI.

Sign in to write a note

Insider activity

Insider buying

$0

Insider selling

$0

Net activity

+$0

Distinct insiders

0

Open-market trades over the last 365 days.

Recent transactions

DateInsiderTypeSharesPriceValue

Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.

Who owns HHS

Institutional value

$2.7M

Total shares held

1.2M

Distinct holders

12

-10 vs prior

As of

2026-03-31

Prior: 2025-12-31

Filers with $100M+ AUM disclose holdings 45 days after quarter end.

Top institutional holders

#ManagerSharesValueQoQ changeAction
1BLAIR WILLIAM & CO/IL660.8K$1.5M+0 (+0.0%)No change
2VANGUARD CAPITAL MANAGEMENT LLC259.0K$588.0KNew
3Krilogy Financial LLC118.2K$339.2K+26.2K (+28.5%)Added
4DIMENSIONAL FUND ADVISORS LP42.6K$96.8K-3.4K (-7.3%)Trimmed
5VANGUARD FIDUCIARY TRUST CO30.6K$69.5KNew
6BlackRock, Inc.28.9K$65.5K+923 (+3.3%)Added
7Vanguard Global Advisers, LLC1.9K$4.4KNew
8UBS Group AG207$470-230 (-52.6%)Trimmed
9Triumph Capital Management86$195+0 (+0.0%)No change
10ACADIAN ASSET MANAGEMENT LLC32.5K$73+0 (+0.0%)No change
11LSV ASSET MANAGEMENT12.7K$29+0 (+0.0%)No change
12WELLS FARGO & COMPANY/MN1$2+0 (+0.0%)No change

Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.

Top questions investors are asking

Coming once HHS's latest filing finishes processing.

Investor sentiment
No votes yet
0 this week · 0 total

Sign in to vote. Votes use 7-day half-life decay.

What matters about HHS?
Tap any that apply. Aggregates show what other investors flag.

Sign in to tap. 7-day half-life decay.

Latest filing impact
After reading, did this filing make you: